Literature DB >> 15072982

Is smoking beneficial for granulomatous lung diseases?

Lisa A Maier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15072982     DOI： 10.1164/rccm.2402023

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  4 in total

1.  "Smoke on the water": a challenging case of pneumonia.

Authors:  Alessandro Milia; Silvia Fruttuoso; Antonio Mancini; Eleonora Riccobono; Fabio Luise; Lucia Sammicheli; Gian Maria Rossolini; Filippo Pieralli
Journal:  Intern Emerg Med       Date:  2022-01-10       Impact factor: 5.472

2.  Novel insights into the aetiology of granulomatosis with polyangiitis-a case-control study using the Clinical Practice Research Datalink.

Authors:  Fiona A Pearce; Peter C Lanyon; Richard A Watts; Matthew J Grainge; Abhishek Abhishek; Richard B Hubbard
Journal:  Rheumatology (Oxford)       Date:  2018-06-01       Impact factor: 7.580

3.  Defining CD4 T helper and T regulatory cell endotypes of progressive and remitting pulmonary sarcoidosis (BRITE): protocol for a US-based, multicentre, longitudinal observational bronchoscopy study.

Authors:  Laura L Koth; Laura D Harmacek; Elizabeth K White; Nicholas Kostandinos Arger; Linda Powers; Brenda R Werner; Roman E Magallon; Pineet Grewal; Briana Q Barkes; Li Li; May Gillespie; Sarah E Collins; Jessica Cardenas; Edward S Chen; Lisa A Maier; Sonia M Leach; Brian P O'Connor; Nabeel Y Hamzeh
Journal:  BMJ Open       Date:  2021-11-09       Impact factor: 3.006

4.  Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people.

Authors:  Julia Hippisley-Cox; Duncan Young; Carol Coupland; Keith M Channon; Pui San Tan; David A Harrison; Kathryn Rowan; Paul Aveyard; Ian D Pavord; Peter J Watkinson
Journal:  Heart       Date:  2020-07-31       Impact factor: 7.365
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.